An overview of Orphan Reinsurer and Benefit Managers groups, including potential challenges with the model and various model suggestions.
Donald Han
Advertisement
Articles by Donald Han
Advertisement
Latest Updated Articles
Improving Management of Gene and Cell TherapiesPublished: September 10th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
2
Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments
3
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
4
Could DTC Programs Help Simplify the Drug-Pricing System?
5
